These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10430768)

  • 1. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice.
    Rouis M; Adamy C; Duverger N; Lesnik P; Horellou P; Moreau M; Emmanuel F; Caillaud JM; Laplaud PM; Dachet C; Chapman MJ
    Circulation; 1999 Aug; 100(5):533-40. PubMed ID: 10430768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis.
    Johnson JL; Baker AH; Oka K; Chan L; Newby AC; Jackson CL; George SJ
    Circulation; 2006 May; 113(20):2435-44. PubMed ID: 16702468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene.
    Silence J; Collen D; Lijnen HR
    Circ Res; 2002 May; 90(8):897-903. PubMed ID: 11988491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors.
    Kashyap VS; Santamarina-Fojo S; Brown DR; Parrott CL; Applebaum-Bowden D; Meyn S; Talley G; Paigen B; Maeda N; Brewer HB
    J Clin Invest; 1995 Sep; 96(3):1612-20. PubMed ID: 7657831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E knockout mice over-expressing human tissue inhibitor of metalloproteinase 1 are protected against aneurysm formation but not against atherosclerotic plaque development.
    Cuaz-Pérolin C; Jguirim I; Larigauderie G; Jlassi A; Furman C; Moreau M; Chapman MJ; Fruchart JC; Slimane MN; Mezdour H; Rouis M
    J Vasc Res; 2006; 43(6):493-501. PubMed ID: 16931892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased medial degradation with pseudo-aneurysm formation in apolipoprotein E-knockout mice deficient in tissue inhibitor of metalloproteinases-1.
    Lemaître V; Soloway PD; D'Armiento J
    Circulation; 2003 Jan; 107(2):333-8. PubMed ID: 12538437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.
    Quarck R; De Geest B; Stengel D; Mertens A; Lox M; Theilmeier G; Michiels C; Raes M; Bult H; Collen D; Van Veldhoven P; Ninio E; Holvoet P
    Circulation; 2001 May; 103(20):2495-500. PubMed ID: 11369691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.
    Luttun A; Lutgens E; Manderveld A; Maris K; Collen D; Carmeliet P; Moons L
    Circulation; 2004 Mar; 109(11):1408-14. PubMed ID: 14993123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice.
    Kuzuya M; Nakamura K; Sasaki T; Cheng XW; Itohara S; Iguchi A
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1120-5. PubMed ID: 16556856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice.
    Juan SH; Lee TS; Tseng KW; Liou JY; Shyue SK; Wu KK; Chau LY
    Circulation; 2001 Sep; 104(13):1519-25. PubMed ID: 11571246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complementary effects of atorvastatin and exercise treatment on the composition and stability of the atherosclerotic plaques in ApoE knockout mice.
    Moustardas P; Kadoglou NP; Katsimpoulas M; Kapelouzou A; Kostomitsopoulos N; Karayannacos PE; Kostakis A; Liapis CD
    PLoS One; 2014; 9(9):e108240. PubMed ID: 25264981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice.
    Bursill CA; Choudhury RP; Ali Z; Greaves DR; Channon KM
    Circulation; 2004 Oct; 110(16):2460-6. PubMed ID: 15477414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice.
    Okamoto Y; Kihara S; Ouchi N; Nishida M; Arita Y; Kumada M; Ohashi K; Sakai N; Shimomura I; Kobayashi H; Terasaka N; Inaba T; Funahashi T; Matsuzawa Y
    Circulation; 2002 Nov; 106(22):2767-70. PubMed ID: 12451000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice.
    Lee TS; Shiao MS; Pan CC; Chau LY
    Circulation; 1999 Mar; 99(9):1222-9. PubMed ID: 10069791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosuvastatin inhibits TIMP-2 and promotes myocardial angiogenesis.
    Siddiqui AJ; Gustafsson T; Sylven C; Crisby M
    Pharmacology; 2014; 93(3-4):178-84. PubMed ID: 24854110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor.
    Eefting D; de Vries MR; Grimbergen JM; Karper JC; van Bockel JH; Quax PH
    J Vasc Surg; 2010 Feb; 51(2):429-37. PubMed ID: 20036101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: relevance to stability of atherosclerotic plaque.
    Moreau M; Brocheriou I; Petit L; Ninio E; Chapman MJ; Rouis M
    Circulation; 1999 Jan; 99(3):420-6. PubMed ID: 9918530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 on atherosclerosis and monocyte/macrophage invasion.
    Di Gregoli K; George SJ; Jackson CL; Newby AC; Johnson JL
    Cardiovasc Res; 2016 Feb; 109(2):318-30. PubMed ID: 26645981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1(-), E3(-), polymerase(-)] adenovirus vector expressing human apoE.
    Harris JD; Graham IR; Schepelmann S; Stannard AK; Roberts ML; Hodges BL; Hill V; Amalfitano A; Hassall DG; Owen JS; Dickson G
    Hum Mol Genet; 2002 Jan; 11(1):43-58. PubMed ID: 11772998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel tocotrienols of rice bran inhibit atherosclerotic lesions in C57BL/6 ApoE-deficient mice.
    Qureshi AA; Salser WA; Parmar R; Emeson EE
    J Nutr; 2001 Oct; 131(10):2606-18. PubMed ID: 11584079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.